New Delhi: Bharat Biotech on Wednesday said a study has demonstrated that booster dose of Covaxin has neutralising effect on the Omicron and Delta variants of COVID-19.
A study conducted at Emory University demonstrated that subjects who received a booster dose of Covaxin (BBV152) six months after getting a primary two-dose series have witnessed neutralising of the SARS-CoV-2 Omicron and Delta variants, the vaccine major said in a statement.
Earlier studies had demonstrated the neutralising potential of Covaxin against other SARS-CoV-2 variants — Alpha, Beta, Delta, Zeta and Kappa, it added.
This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Also read: Doctors alarmed by ‘strange’ new ICMR rule that makes Covid test optional for hospital patients